Curran Simpson

Curran Simpson is a declared insider at 2 companies; the most frequent names are Human Genome Sciences Inc and REGENXBIO Inc. In total, 167 filings cover trades dated from 10 March 2007 to 1 July 2026.

Sales make up the whole of the open-market record (70 sales, €21.2M). Besides market trades, the filings include 27 share grants and 65 option exercises.

Most recently, on 6 July 2026, the filings show a share grant worth €5,663 in REGENXBIO Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.